The science
More than 1,000 peer-reviewed studies. 166 disease models explored. Human trials spanning cardiac arrest, Parkinson's, COVID-19, athletic recovery and hypertension. Below, 35 of the most significant studies — cited directly from primary sources.
Explore the researchWhy hydrogen is different
Most antioxidants are blunt instruments. Vitamin C, vitamin E, glutathione — they neutralise free radicals indiscriminately, including the reactive oxygen species the body actually needs for cell signalling, immune defence and the regulation of growth.
What makes the research compelling is not only where hydrogen goes, but what it does when it arrives. Studies describe it as a selective antioxidant — targeting the most destructive free radicals, while leaving the beneficial reactive molecules that cells use for signalling largely intact.
Hydrogen acts as a selective antioxidant by reducing cytotoxic oxygen radicals. — Ohsawa et al., Nature Medicine, 2007
The mechanism
Four steps, from purified water to cellular level — in under a minute. The technology is precise, the physics is elegant, and the journey is short.
A USA-manufactured Proton Exchange Membrane splits purified water into pure molecular hydrogen gas. No additives, no by-products. Just water in, H₂ out.
You breathe through a soft nasal cannula at normal resting breath, typically for 20 to 60 minutes. The hydrogen reaches the lungs immediately on inhalation — no sensation, no effort.
H₂ crosses the lung-blood barrier within seconds, entering the bloodstream and distributing rapidly. Research suggests measurable plasma concentrations are reached within the first few breaths.
Being the smallest molecule in existence, H₂ crosses cell membranes freely — reaching the mitochondria, brain tissue and muscle at the cellular level, where the research suggests it can act on oxidative stress.
A note on the evidence
The research on molecular hydrogen is unusually strong for a young field — but it is still a young field. Many of the disease models cited in the literature are animal studies; the human trials below tend to be small, single-centre and early-stage, with a handful of larger randomised controlled trials. Most are promising. None should be read as the final word. Where we cite a study, we link to PubMed or the journal DOI so you can read the abstract — and, where it is open access, the full paper — yourself. We use the language the studies use: "was associated with", "may support", "research suggests". Not as a legal hedge, but because that is honestly where the evidence stands. H2 Pure Life machines are wellness devices, not medical devices. Individual results vary. For medical concerns, please consult a qualified healthcare professional.
Peer-reviewed research
Showing all 35 studies.
Nature Medicine · 2007 · Animal RCT
The foundational paper. Ohsawa and colleagues showed that inhaled hydrogen selectively neutralised the most damaging free radicals while leaving beneficial reactive oxygen species intact.
Established hydrogen as a selective antioxidant in mammalian models.
Read on PubMedeClinicalMedicine · 2023 · Human RCT
The first multicentre, randomised, double-blind, placebo-controlled trial of hydrogen inhalation in post-cardiac-arrest care, run across 15 Japanese hospitals. Comatose survivors of out-of-hospital cardiac arrest received 2% hydrogen with oxygen, or oxygen alone, for 18 hours.
The primary outcome — good neurological recovery at 90 days — did not reach statistical significance; secondary outcomes favoured hydrogen, with higher 90-day survival (85% vs 61%) and less disability.
Read on PubMedJournal of Thoracic Disease · 2020 · Human trial
A multicentre Chinese study evaluated hydrogen/oxygen gas mixture inhalation in hospitalised COVID-19 patients, measuring symptom severity and recovery time.
Hydrogen/oxygen inhalation was associated with improvement in disease severity scores.
Read on PubMedMovement Disorders · 2013 · Human RCT
A randomised, double-blind, placebo-controlled pilot at Juntendo University. Patients on levodopa drank 1,000 ml/day of hydrogen-rich water — not inhaled hydrogen — or placebo water, for 48 weeks.
Hydrogen-rich water was associated with improved total Unified Parkinson's Disease Rating Scale scores in this small pilot.
Note: A 2018 follow-up by the same author (Yoritaka A et al., Movement Disorders 33:1505–1507) in a larger sample did not replicate the finding, and a 2021 hydrogen inhalation pilot by the same group also showed no significant effect. This 2013 water study is retained for completeness; it is not inhalation evidence.
Read on PubMedCritical Care Explorations · 2021 · Human safety study
Eight healthy adults, prolonged hydrogen inhalation 24–72 hours at 2.4% via high-flow nasal cannula. Endpoints included pulmonary function testing, vital signs, neurological exam, serologic markers. No clinically significant adverse effects.
Prolonged hydrogen inhalation was well tolerated with no clinically significant changes in pulmonary function or other safety markers in healthy adults.
Read on PubMedMedical Gas Research · 2025 · Human RCT
20 physically active women, double-blind placebo-controlled crossover, 60 min hydrogen inhalation at 300 ml/min via nasal cannula. Significant RER decrease across all 15-minute intervals; effect correlated with body fat percentage.
60 minutes of hydrogen inhalation was associated with increased fat oxidation at rest.
Read on PubMedMedical Gas Research · 2012 · Human pilot
Twenty patients with rheumatoid arthritis drank hydrogen-rich water for four weeks, followed by a four-week washout and a second four-week drinking period.
Hydrogen water was associated with reductions in disease activity scores and urinary 8-OHdG.
Read on PubMedCirculation Journal · 2017 · Human trial
A prospective, open-label, rater-blinded pilot in 20 patients with ST-elevation myocardial infarction, comparing hydrogen inhalation plus oxygen against oxygen alone alongside standard PCI. Left ventricular remodelling was assessed by cardiac MRI.
The primary cardiac-salvage measure showed no significant between-group difference; left-ventricular measures at six months favoured the hydrogen group numerically.
Read on PubMedJournal of Stroke and Cerebrovascular Diseases · 2017 · Human RCT
A Japanese single-centre trial evaluated hydrogen gas inhalation alongside standard stroke care, measuring NIHSS scores and functional recovery at 90 days.
Hydrogen inhalation was associated with improved NIHSS scores at discharge.
Read on PubMedJournal of Lipid Research · 2013 · Human pilot
An open-label 10-week pilot study measured serum LDL cholesterol, HDL function and urinary oxidative stress markers in patients with metabolic syndrome.
Hydrogen water was associated with reduced LDL cholesterol and improved HDL function.
Read on PubMedQJM: An International Journal of Medicine · 2020 · Prospective study
Single 45-minute hydrogen inhalation session reduced airway inflammatory mediators in human subjects with asthma or COPD. Mechanism-relevant data for the selective antioxidant effect in respiratory tissue.
Single 45-min inhalation reduced MCP-1 levels in both COPD and asthma groups; reduced IL-8 in asthma group.
Read on PubMedMedical Gas Research · 2020 · Human clinical trial
Eight physically active men inhaled a hydrogen-rich gas mixture through a nasal cannula during a 60-minute recovery period after strenuous exercise, in a double-blind placebo-controlled crossover. Oxidative-stress and muscle-damage markers and subsequent performance were measured.
Hydrogen inhalation during recovery was associated with an attenuated decline in subsequent jump performance; effects on oxidative-stress markers were mixed.
Read on PubMedFrontiers in Pharmacology · 2022 · Human RCT
A randomised, placebo-controlled trial in adults aged 50–70 with hypertension. Participants inhaled a low-dose hydrogen-oxygen mixture, or placebo air, four hours a day for two weeks, with four-limb and 24-hour ambulatory blood pressure monitored throughout.
Systolic blood pressure fell significantly from baseline in the hydrogen-oxygen group, with a reduction in night-time diastolic ambulatory pressure; placebo was unchanged.
Read on PubMedMedical Gas Research · 2011 · Human RCT
A randomised placebo-controlled trial measured quality-of-life scores and side-effect severity in patients receiving radiotherapy for liver cancer.
Hydrogen water drinkers reported better quality-of-life scores during radiotherapy.
Read on PubMedDiabetes, Metabolic Syndrome and Obesity · 2020 · Human RCT
A 24-week randomised trial measured changes in body fat percentage, waist circumference and metabolic markers in adults with elevated BMI.
Hydrogen-rich water was associated with reduced cholesterol, glucose and HbA1c; the change in body-fat measures was a non-significant trend.
Read on PubMedCurrent Alzheimer Research · 2018 · Human RCT
A 12-month randomised, double-blind, placebo-controlled trial. Adults with mild cognitive impairment received either hydrogen-rich water or placebo water daily. ADAS-cog was the primary cognitive outcome.
Hydrogen water significantly improved ADAS-cog scores in the APOE4-genotype subgroup — the cohort most genetically vulnerable to brain oxidative stress.
Read on PubMedMedical Gas Research · 2017 · Human trial
Healthy adults — not patients — drank hydrogen-rich water daily across a four-week intervention. Mood inventories, anxiety scores, and autonomic nervous function were measured.
Hydrogen water was associated with improvements in subjective mood and objective autonomic nervous balance in healthy adults.
Read on PubMedScientific Reports · 2020 · Human RCT
A 4-week double-blind controlled trial in healthy adults aged 20-59. Hydrogen-rich water consumed at 1.5 L daily. Outcomes measured at the transcriptomic level — gene expression networks, immune cell apoptosis, antioxidant potential.
Pro-inflammatory signalling pathways (TLR, NF-κB) showed reduced transcription; immune cell apoptosis was significantly lower in the hydrogen group.
Read on PubMedInternational Immunopharmacology · 2014 · Human RCT
A clinical pilot trial at Haradoi Hospital following the 2012 open-label signal. Patients with rheumatoid arthritis received hydrogen-infused saline or placebo. Disease activity scores were the primary endpoint.
Hydrogen-infused saline was associated with measurable reductions in disease activity compared with placebo.
Read on PubMedBiology of Sport · 2019 · Human RCT
A 7-day double-blind placebo-controlled crossover. Participants inhaled either 4% hydrogen or room air for 20 minutes a day, with a washout period between conditions.
Peak running velocity in an incremental maximal test rose by up to 4.2% on hydrogen versus placebo; authors framed the molecule as showing “ergogenic properties”.
Read on PubMedMedical Gas Research · 2012 · Human pilot
Double-blind crossover pilot. Hydrogen-rich water consumed before heavy exercise; blood lactate and muscle function were measured during and after the bout.
Hydrogen-rich water prevented the usual rise in blood lactate and reduced the early decline in muscle function versus placebo.
Read on PubMedFrontiers in Physiology · 2024 · Human RCT
Double-blind placebo-controlled crossover. Elite fin swimmers completed two strenuous training sessions on the same day with hydrogen-rich water or placebo; recovery markers were measured at 24 hours.
The hydrogen group showed measurably better muscle recovery markers at the 24-hour mark.
Read on PubMedJournal of Clinical Medicine Research · 2020 · Pharmacokinetic
Pharmacokinetic study using three micro miniature pigs. Pure hydrogen inhaled through a standard nasal cannula at a low flow rate of 250 ml/min; arterial blood hydrogen concentrations were measured.
A low-flow nasal cannula delivered arterial blood hydrogen at concentrations the wider literature considers therapeutically active.
Read on PubMedVascular Health and Risk Management · 2014 · Human RCT
Placebo-controlled trial. Healthy adults consumed water with dissolved molecular hydrogen; flow-mediated dilation — the standard non-invasive test of endothelial responsiveness — was measured before and after.
Flow-mediated dilation rose in the high-hydrogen group and fell in the placebo group; endothelial responsiveness improved measurably.
Read on PubMedPLOS One · 2020 · Human RCT
A 14-day placebo-controlled trial in healthy adults. Peripheral endothelial function was measured by reactive hyperemia index — a finer-grained smaller-vessel response test.
The hydrogen group showed improved reactive hyperemia scores; authors concluded that continuous consumption of high-H2 water contributes to improved cardiovascular health.
Read on PubMedNutrition Research · 2008 · Human RCT
An 8-week double-blind placebo-controlled crossover trial. Adults with impaired glucose tolerance or diabetes consumed 900 ml/day of hydrogen-rich water or placebo. Lipid markers and glucose metabolism markers were measured.
Hydrogen-rich water was associated with reductions in oxidised LDL and improvements in lipoprotein metabolism markers.
Read on PubMedJournal of Clinical Biochemistry and Nutrition · 2010 · Human pilot
A 10-week open-label trial in adults with features of metabolic syndrome. Participants consumed 1.5–2.0 L/day of hydrogen-rich water. Urinary thiobarbituric acid reactive substances, antioxidant enzyme activity and serum lipid markers were measured.
Hydrogen-rich water was associated with improved antioxidant enzyme activity and favourable changes in lipid metabolism markers.
Read on PubMedScientific Reports · 2019 · Animal pharmacokinetic
Real-time tissue hydrogen monitoring during and after inhalation in rats. Hydrogen concentrations were measured directly in liver, kidney, mesentery fat, skeletal muscle and brain.
Inhaled hydrogen reached liver, kidney, mesentery fat and skeletal muscle in measurable concentrations within minutes.
Read on PubMedAntioxidants (Basel) · 2023 · Human RCT
Seventy-three IFG patients, double-blind placebo-controlled, 8 weeks of 1000 ml/day hydrogen-rich water. Modest improvements in metabolic parameters with concurrent shifts in gut microbiota composition.
Hydrogen-rich water was associated with modest improvements in metabolic parameters and favourable shifts in gut microbiota composition.
Read on PubMedPharmacology & Therapeutics · 2014 · Review
Seven-year mechanism review by the lab that proposed the selective-antioxidant hypothesis. Tracks how the field developed from the 2007 founding paper through 2014 across more than 38 diseases, physiological states and clinical tests.
Mechanism held up under scrutiny; signalling modulation, anti-inflammatory effects and Nrf2 engagement added to the picture.
Read on PubMedMedical Gas Research · 2015 · Review
Comprehensive accounting of 321 original research articles on H2’s biological effects published between 2007 and mid-2015. Establishes the breadth of the field across neurological, cardiovascular, metabolic, inflammatory and respiratory systems.
Established the breadth of hydrogen's biological activity across physiological systems through the field's first decade.
Read on PubMedCell · 2013 · Review
Not a hydrogen study, but the framework on which serious ageing research now sits. Five authors set out nine cellular hallmarks of ageing — including mitochondrial dysfunction and the oxidative stress that accompanies it — that have become the standard map of what changes as cells age. Among the most cited papers in biology.
Established the dominant cellular framework for studying ageing — including the mitochondrial and oxidative-stress pathways hydrogen research addresses.
Read on PubMedBiochimica et Biophysica Acta · 2012 · Review
A focused review of hydrogen at the mitochondrial level by the head of the lab that proposed the selective-antioxidant hypothesis. Argues that mitochondria are the major source of cellular oxidative stress and that persistent oxidative stress is one of the factors involved in the ageing process.
Connected the selective-antioxidant mechanism directly to mitochondrial dysfunction and the biology of cellular ageing.
Read on PubMedScientific Reports · 2016 · Cell study
From the same lab as the 2007 founding paper. Showed that hydrogen can influence gene expression — not by acting on DNA directly, but by modifying the chain of oxidised-lipid signals that cells use to regulate their own activity.
Demonstrated that hydrogen acts on the cell's regulatory machinery, not only as a radical scavenger.
Read on PubMedMedical Gas Research · 2026 · Human RCT
A single-blind, randomised controlled trial in 66 adults with sleep disorders across two Chinese hospitals. Participants received seven days of nasal hydrogen-oxygen inhalation or standard care, with sleep tracked objectively by actigraphy alongside the Pittsburgh Sleep Quality Index and mood scales.
The hydrogen-oxygen group showed greater total sleep time and sleep efficiency and less wake time, with lower PSQI scores (indicating better sleep quality) and lower depression scores; anxiety scores did not differ significantly. Early evidence from a small, two-site trial that may support better sleep.
Read on PubMedSafety profile
In a formal safety study published in Scientific Reports, nine healthy adults inhaled hydrogen continuously for 72 hours. Continuous ECG, vital signs, and full laboratory panels were monitored throughout. No adverse events. No ECG changes. No clinically significant lab abnormalities.
We reference this study not as a recommendation for duration, but as context. It is the most rigorous continuous-exposure human safety data available for molecular hydrogen inhalation — and the findings are reassuring.
H2 Pure Life sessions run 20–60 minutes. We let that contrast speak for itself.
From the research to the day
The studies above are the foundation. Where the research suggests hydrogen can help most — energy, recovery, cognition, sleep — is laid out plainly on the use cases page. Or, if you would rather see the machines that deliver it, start there.